Wealthsource Partners LLC raised its stake in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) by 17.6% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 66,900 shares of the company’s stock after buying an additional 10,000 shares during the period. Wealthsource Partners LLC’s holdings in ProShares UltraShort Nasdaq Biotechnology were worth $1,046,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in BIS. Healthcare Value Capital LLC increased its stake in ProShares UltraShort Nasdaq Biotechnology by 20.0% during the 2nd quarter. Healthcare Value Capital LLC now owns 150,000 shares of the company’s stock valued at $2,921,000 after buying an additional 25,000 shares during the period. Virtu Financial LLC increased its stake in ProShares UltraShort Nasdaq Biotechnology by 132.4% during the 3rd quarter. Virtu Financial LLC now owns 34,896 shares of the company’s stock valued at $545,000 after buying an additional 19,879 shares during the period. HRT Financial LLC acquired a new position in ProShares UltraShort Nasdaq Biotechnology during the 2nd quarter valued at about $220,000. Finally, Jane Street Group LLC increased its stake in ProShares UltraShort Nasdaq Biotechnology by 75.3% during the 2nd quarter. Jane Street Group LLC now owns 18,823 shares of the company’s stock valued at $366,000 after buying an additional 8,084 shares during the period.

ProShares UltraShort Nasdaq Biotechnology stock opened at $19.51 on Thursday. ProShares UltraShort Nasdaq Biotechnology has a 52 week low of $15.38 and a 52 week high of $24.48.

TRADEMARK VIOLATION WARNING: “ProShares UltraShort Nasdaq Biotechnology (BIS) Shares Bought by Wealthsource Partners LLC” was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this report can be read at https://www.watchlistnews.com/proshares-ultrashort-nasdaq-biotechnology-bis-shares-bought-by-wealthsource-partners-llc/2665067.html.

About ProShares UltraShort Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.

See Also: How Does the Quiet Period Work?

Want to see what other hedge funds are holding BIS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS).

Institutional Ownership by Quarter for ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)

Receive News & Ratings for ProShares UltraShort Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.